IDARUCIZUMAB Pharmacologic Class Indexing

Class set ID
4aa881d7-89ed-4ee5-9da4-655118f62330
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use PRAXBIND safely and effectively. See full prescribing information for PRAXBIND. PRAXBIND ® (idarucizumab) injection, for intravenous use Initial U.S. Approval: 2015Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim Pharma GmbH and Co. KG202401238